lorazepam has been researched along with Depression in 24 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
Excerpt | Relevance | Reference |
---|---|---|
" Citalopram, a newer generation SSRI, is commonly prescribed, but despite its low toxicity profile has a potential to cause seizures and dysarrythmias in overdose." | 7.76 | Metabolic acidosis and generalized seizures secondary to citalopram overdose: a case report. ( Al Anazi, T; Al Hayyan, H; Al Hussein, M; Al Modaimegh, H; Al Qahtani, M; Bin Salih, S, 2010) |
"Aripiprazole was associated with beneficial effects on mood in patients with bipolar depression, and appears well tolerated with very small changes in mean body weight." | 5.13 | Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. ( Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR, 2008) |
"In 60 patients undergoing a curettage in thiopentone induced inhalation anaesthesia with enflurane and N2O/O2 = 2:1, the effects of oral premedication (2 h before anaesthesia) with 30 mg morphine (MST 30) (n = 21), 1 mg lormetazepam (Noctamid) (n = 19) and placebo (n = 21) on psychological (anxiety, depression and asthenia), physiological (blood pressure, heart and respiratory rate) and pain parameters (visual analogue scale, analgesic consumption) were investigated." | 5.06 | [Effect and side effects of oral morphine, lormetazepam and placebos as premedication]. ( Hartung, M; Hettenbach, A; Krug, C; Tolksdorf, W, 1987) |
"From a retrospective cohort of clinically depressed patients that were treated with rTMS, we compared 176 patients not taking any BZD with 73 patients taking lorazepam with respect to changes in the Hamilton Depression Rating Scale (HRDS)." | 4.02 | Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting. ( Abdelnaim, M; Deppe, M; Hebel, T; Kreuzer, PM; Langguth, B; Poeppl, TB; Schecklmann, M, 2021) |
"The World Health Organization recommends that anxiety, depression, agitation and delirium at end of life should be treated with drugs such as lorazepam, diazepam, midazolam and haloperidol." | 3.83 | Look again at psychedelic drugs. ( Cameron, R, 2016) |
" Citalopram, a newer generation SSRI, is commonly prescribed, but despite its low toxicity profile has a potential to cause seizures and dysarrythmias in overdose." | 3.76 | Metabolic acidosis and generalized seizures secondary to citalopram overdose: a case report. ( Al Anazi, T; Al Hayyan, H; Al Hussein, M; Al Modaimegh, H; Al Qahtani, M; Bin Salih, S, 2010) |
"Aripiprazole was superior to placebo in delaying time to manic relapse (p = ." | 2.73 | Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. ( Calabrese, JR; Carlson, BX; Carson, WH; Eudicone, JM; Keck, PE; Marcus, RN; McIntyre, RS; McQuade, RD; Sanchez, R, 2007) |
"He was diagnosed with catatonia and treated successfully with lorazepam." | 1.51 | Temporal glioblastoma presenting as catatonia. ( Franssen, A; Sienaert, P, 2019) |
"The seizure was successfully treated with benzodiazepines." | 1.32 | Seizure secondary to citalopram overdose. ( Cuenca, PJ; Hoefle, JD; Holt, KR, 2004) |
"lorazepam t." | 1.25 | Treatment of 'brain fag' syndrome. ( Anumonye, A, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (29.17) | 18.7374 |
1990's | 3 (12.50) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 8 (33.33) | 24.3611 |
2020's | 3 (12.50) | 2.80 |
Authors | Studies |
---|---|
Laurin, A | 1 |
Capelle, N | 1 |
Bukowski, N | 1 |
Le Page, A | 1 |
Gendre, I | 1 |
Sauvaget, A | 1 |
Bulteau, S | 1 |
Pérez, T | 1 |
Pardo, MC | 1 |
Cabellos, Y | 1 |
Peressini, M | 1 |
Ureña-Vacas, I | 1 |
Serrano, DR | 1 |
González-Burgos, E | 1 |
Deppe, M | 1 |
Abdelnaim, M | 1 |
Hebel, T | 1 |
Kreuzer, PM | 1 |
Poeppl, TB | 1 |
Langguth, B | 1 |
Schecklmann, M | 1 |
Franssen, A | 1 |
Sienaert, P | 1 |
Hadar, R | 1 |
Edemann-Callesen, H | 1 |
Hlusicka, EB | 1 |
Wieske, F | 1 |
Vogel, M | 1 |
Günther, L | 1 |
Vollmayr, B | 1 |
Hellweg, R | 1 |
Heinz, A | 1 |
Garthe, A | 1 |
Winter, C | 1 |
Nishiyama, A | 1 |
Matsumoto, H | 1 |
Huang, TH | 1 |
Hong, CJ | 1 |
Avalos-Franco, N | 1 |
Castellar-Cerpa, J | 1 |
Santos-Bueso, E | 1 |
Sáenz-Francés, F | 1 |
García Sánchez, J | 1 |
Khalafian, A | 1 |
Dukes, C | 1 |
Tucker, P | 1 |
Cameron, R | 1 |
Mazza, M | 1 |
Squillacioti, MR | 1 |
Pecora, RD | 1 |
Janiri, L | 1 |
Bria, P | 1 |
Bin Salih, S | 1 |
Al Qahtani, M | 1 |
Al Anazi, T | 1 |
Al Hussein, M | 1 |
Al Hayyan, H | 1 |
Al Modaimegh, H | 1 |
Cuenca, PJ | 1 |
Holt, KR | 1 |
Hoefle, JD | 1 |
Keck, PE | 1 |
Calabrese, JR | 1 |
McIntyre, RS | 1 |
McQuade, RD | 1 |
Carson, WH | 1 |
Eudicone, JM | 1 |
Carlson, BX | 1 |
Marcus, RN | 1 |
Sanchez, R | 1 |
Fitzal, S | 1 |
Groll-Knapp, E | 1 |
Länger, W | 1 |
Riegler, R | 1 |
Laakman, G | 1 |
Faltermaier-Temizel, M | 1 |
Bossert-Zaudig, S | 1 |
Baghai, T | 1 |
Lorkowski, G | 1 |
Lynch, G | 1 |
Green, JF | 1 |
King, DJ | 1 |
McCurdy, L | 1 |
Schatzberg, AF | 1 |
Anumonye, A | 1 |
Philipp, M | 1 |
Göttinger, E | 1 |
Petracca, A | 1 |
Michelini, S | 1 |
Perugi, G | 1 |
Cassano, GB | 1 |
Tolksdorf, W | 1 |
Krug, C | 1 |
Hartung, M | 1 |
Hettenbach, A | 1 |
Manfè, AZ | 1 |
Bonea, M | 1 |
Da Rold, A | 1 |
Maffei Faccioli, A | 1 |
Terranova, O | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00036348] | Phase 3 | 0 participants | Interventional | 2000-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 trials available for lorazepam and Depression
Article | Year |
---|---|
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Ag | 2008 |
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depression; Diagnostic and Statistical | 2007 |
[Premedication with flunitrazepam, lormetazepam or pethidine-promethazine. Psychometric study of subjective conditions].
Topics: Adult; Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Depression; Emotions; Flunitrazepam; | 1983 |
Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Antidepressive Agents; Depression; Female; Humans; Lorazepam | 1995 |
Antipsychotic drug-induced dysphoria.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Depression; Double-Blind Method; H | 1996 |
Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Depression; D | 1978 |
[Benzodiazepine withdrawal syndrome. Problems of differential diagnosis against depression, panic attacks and generalized anxiety].
Topics: Anxiety; Benzodiazepines; Depression; Diagnosis, Differential; Double-Blind Method; Humans; Lorazepa | 1991 |
[Effect and side effects of oral morphine, lormetazepam and placebos as premedication].
Topics: Administration, Oral; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as Topic; Depre | 1987 |
16 other studies available for lorazepam and Depression
Article | Year |
---|---|
[Ketamine and lorazepam combination as an alternative to electroconvulsive therapy for catatonia in late-life depression: A case report].
Topics: Catatonia; Depression; Electroconvulsive Therapy; Humans; Ketamine; Lorazepam | 2023 |
Mental health and drug use in college students: Should we take action?
Topics: Anxiety; COVID-19; Depression; Humans; Lorazepam; Mental Health; Students; Substance-Related Disorde | 2023 |
Concomitant lorazepam use and antidepressive efficacy of repetitive transcranial magnetic stimulation in a naturalistic setting.
Topics: Depression; Depressive Disorder, Major; Female; Humans; Lorazepam; Male; Middle Aged; Retrospective | 2021 |
Temporal glioblastoma presenting as catatonia.
Topics: Anti-Anxiety Agents; Catatonia; Chemotherapy, Adjuvant; Depression; Glioblastoma; Humans; Lorazepam; | 2019 |
Recurrent stress across life may improve cognitive performance in individual rats, suggesting the induction of resilience.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Cognition; Depression; Disease Models, Animal; Loraz | 2019 |
Quetiapine reduces irritability and risk of suicide in patients with agitated depression.
Topics: Antipsychotic Agents; Anxiety; Depression; Dibenzothiazepines; Drug Therapy, Combination; Female; Hu | 2013 |
Meningioma presenting with treatment-refractory depression.
Topics: Antiemetics; Depression; Female; Humans; Lorazepam; Meningeal Neoplasms; Meningioma; Middle Aged | 2014 |
Angle closure secondary to the use of lorazepam in patient with myopia magna.
Topics: Acetazolamide; Cholinergic Antagonists; Combined Modality Therapy; Depression; Dexamethasone; Diseas | 2015 |
Consultation Dilemma Catatonia in a Patient with Prior TBI: MentaI or Medical Disorder?
Topics: Adult; Anticonvulsants; Behavior Observation Techniques; Brain Injuries; Catatonia; Depression; Diag | 2015 |
Look again at psychedelic drugs.
Topics: Anxiety; Delirium; Depression; Diazepam; Hallucinogens; Haloperidol; Humans; Lorazepam; Midazolam; P | 2016 |
Metabolic acidosis and generalized seizures secondary to citalopram overdose: a case report.
Topics: Acidosis; Anticonvulsants; Citalopram; Depression; Drug Overdose; Female; Humans; Lorazepam; Seizure | 2010 |
Seizure secondary to citalopram overdose.
Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; | 2004 |
Treatment of 'brain fag' syndrome.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Depression; Humans; Lorazepam; Male; Nige | 1975 |
[Course of depression after sleep deprivation (author's transl)].
Topics: Depression; Female; Humans; Lithium; Lorazepam; Male; Middle Aged; Sleep Deprivation; Time Factors | 1978 |
[The incidence of masked depression in gynecological practice].
Topics: Anthracenes; Depression; Drug Combinations; Female; Flupenthixol; Humans; Lorazepam; Medical History | 1978 |
[A case of dynamic ileus caused by tricyclic antidepressive agents].
Topics: Antidepressive Agents, Tricyclic; Depression; Desipramine; Drug Therapy, Combination; Female; Humans | 1988 |